Medirom (MRM) director Nojima Akira reports holding 1,200 common shares
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Medirom Healthcare Technologies Inc. director Nojima Akira has reported initial beneficial ownership of 1,200 Common Shares. These shares are held directly, and the filing does not reflect any recent buy or sell activity, only the director’s current equity position in the company.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Nojima Akira
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Shares | -- | -- | -- |
Holdings After Transaction:
Common Shares — 1,200 shares (Direct)
Footnotes (1)
FAQ
What does Nojima Akira’s Form 3 filing for MRM show?
The Form 3 shows that director Nojima Akira beneficially owns 1,200 Common Shares of Medirom Healthcare Technologies Inc. This filing records an existing ownership position rather than reporting a new purchase or sale of shares.
Is the Form 3 for Medirom (MRM) a routine insider ownership filing?
Yes. The Medirom (MRM) Form 3 is a routine insider ownership filing that records 1,200 Common Shares held by director Nojima Akira. It establishes baseline ownership rather than signaling a new trading decision.
Does Medirom’s Form 3 filing indicate any derivative securities for Nojima Akira?
The filing only shows Common Shares and reports 1,200 shares held after the reporting date. No derivative securities, such as options or warrants, are listed for director Nojima Akira in this Form 3 summary.